Clinical trial
The Drug-drug Interaction of SP2086 and Metformin
NCT02813863 is registered in ClinicalTrials.gov with Jiangsu HengRui Medicine Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Drug-drug Interaction of SP2086 and Metformin
- Lead sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- December 31, 2015
- Completion date
- Not reported
- Enrollment
- 24 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
type 2 diabetes